Control of vascular permeability by atrial natriuretic peptide via a GEF-H1-dependent mechanism

J Biol Chem. 2014 Feb 21;289(8):5168-83. doi: 10.1074/jbc.M113.493924. Epub 2013 Dec 18.

Abstract

Microtubule (MT) dynamics is involved in a variety of cell functions, including control of the endothelial cell (EC) barrier. Release of Rho-specific nucleotide exchange factor GEF-H1 from microtubules activates the Rho pathway of EC permeability. In turn, pathologic vascular leak can be prevented by treatment with atrial natriuretic peptide (ANP). This study investigated a novel mechanism of vascular barrier protection by ANP via modulation of GEF-H1 function. In pulmonary ECs, ANP suppressed thrombin-induced disassembly of peripheral MT and attenuated Rho signaling and cell retraction. ANP effects were mediated by the Rac1 GTPase effector PAK1. Activation of Rac1-PAK1 promoted PAK1 interaction with the Rho activator GEF-H1, inducing phosphorylation of total and MT-bound GEF-H1 and leading to attenuation of Rho-dependent actin remodeling. In vivo, ANP attenuated lung injury caused by excessive mechanical ventilation and TRAP peptide (TRAP/HTV), which was further exacerbated in ANP(-/-) mice. The protective effects of ANP against TRAP/HTV-induced lung injury were linked to the increased pool of stabilized MT and inactivation of Rho signaling via ANP-induced, PAK1-dependent inhibitory phosphorylation of GEF-H1. This study demonstrates a novel protective mechanism of ANP against pathologic hyperpermeability and suggests a novel pharmacological intervention for the prevention of increased vascular leak via PAK1-dependent modulation of GEF-H1 activity.

Keywords: Endothelial Dysfunction; Lung Injury; Microtubules; Permeability; Rho GTPases; Signal Transduction; Vascular Biology.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Actins / metabolism
  • Acute Lung Injury / enzymology
  • Acute Lung Injury / pathology
  • Animals
  • Atrial Natriuretic Factor / metabolism*
  • Atrial Natriuretic Factor / pharmacology
  • Capillary Permeability* / drug effects
  • Cytoprotection / drug effects
  • Disease Models, Animal
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Genes, Dominant
  • HEK293 Cells
  • Humans
  • Lung / blood supply
  • Lung / pathology
  • Mice
  • Mice, Inbred C57BL
  • Microtubules / drug effects
  • Microtubules / metabolism
  • Models, Biological
  • Myosin Light Chains / metabolism
  • Phosphorylation / drug effects
  • Pneumonia / enzymology
  • Pneumonia / pathology
  • Protein Binding / drug effects
  • Rho Guanine Nucleotide Exchange Factors / metabolism*
  • Thrombin / pharmacology
  • p21-Activated Kinases / metabolism
  • rac1 GTP-Binding Protein / metabolism

Substances

  • ARHGEF2 protein, human
  • Actins
  • Myosin Light Chains
  • Rho Guanine Nucleotide Exchange Factors
  • Atrial Natriuretic Factor
  • p21-Activated Kinases
  • Thrombin
  • rac1 GTP-Binding Protein